Lung and breast cancer mortality among women in France: Future trends |
| |
| Authors: | Daniel Eilstein Kanwal Eshai |
| |
| Institution: | 1. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA;2. Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA;3. The Multi-Regional Clinical Trials Center of Brigham and Women''s Hospital and Harvard, Boston, MA, USA;4. Department of Surgery, Daegu Catholic University, School of Medicine, Daegu, Republic of Korea;5. Department of Medical Statistics & Informatics, Daegu Catholic University, School of Medicine, Daegu, Republic of Korea;6. Department of Breast Disease, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China;7. Department of Diagnostics, College of Korean Medicine, Daegu Haany University, Daegu, Republic of Korea;1. Pharmacology Department, Medical Faculty, University of Nis, Nis, Serbia;2. Pharmacology and Toxicology Department, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia;3. Department of Pharmacy, Medical Faculty, University of Nis, Nis, Serbia;4. Department of Internal Medicine—Cardiology, Medical Faculty, University of Nis, Nis, Serbia;5. Clinic for Cardiovascular Diseases, Clinical Centre Nis, Serbia;6. Laboratory for Functional Genomics and Proteomics, Research Center for Biomedicine, Medical Faculty, University of Nis, Nis, Serbia;7. Institute of Biochemistry, Medical Faculty, University of Nis, Nis, Serbia;8. Department of Gynecology and Obstetrics, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia;9. Department of Pharmacy, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia |
| |
| Abstract: | Estimates of mortality in future years are crucial for communication, prevention and anticipation related to the burden of diseases and for developing scenarios studying the effects of reducing environmental exposure. The aim of this study is to project observed trends of mortality in France for lung and breast cancer among females to 2021. Projections of mortality rates are based on a Bayesian age-period-cohort model and a Poisson distribution. We used cancer mortality data from the French mortality register (period 1977–2006) and population data from population registers (estimated for 1977–2006 and projected for period 2007–2021 using five scenarios: largest, smallest, youngest, older, average population). Alternative models were tested (generalized additive model, negative binomial distribution).For the average population scenario, lung and breast cancer mortality rates age-standardized to the world population, are respectively: 11.5 per 105 women (Credibility interval: 10.3–12.8) and 15.9 (14.4–17.6) in 2007–2011, 14.6 (11.7–18.1) and 14.5 (11.6–18.0) in 2012–2016, 18.2 (12.6–26.0) and 13.3 (9.1–18.9) in 2017–2021.Projections show an ongoing increase for lung cancer and decrease for breast cancer mortality rates, which are expected to be equal in 2012–2016. Compared projections of these two cancers using a similar method had not been done before. Aggressive prevention strategies targeting smoking among women are needed to control this fast growing epidemic of avoidable cancer. Planning of health care capacity for diagnosis and treatment of cancer among females is also necessary. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
